Efficacy and Safety of apatinib in patients with intermediate/advanced hepatocellular carcinoma: A prospective observation study

This prospective study aimed to evaluate the efficacy and safety of apatinib in patients with intermediate/advanced hepatocellular carcinoma (HCC). The patients with intermediate/advanced HCC, who met predetermined inclusion and exclusion criteria, underwent oral treatment of apatinib 500 mg daily....

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Wen-Chang, Zhang, Kong-Zhi, Chen, Shi-Guang, Liu, Wei-Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
6800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779795/
https://www.ncbi.nlm.nih.gov/pubmed/29505026
http://dx.doi.org/10.1097/MD.0000000000009704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779795/
https://www.ncbi.nlm.nih.gov/pubmed/29505026
http://dx.doi.org/10.1097/MD.0000000000009704

Ejemplares similares